SG10201704135QA - Method For Eliciting An Immune Response To An Immunogen - Google Patents

Method For Eliciting An Immune Response To An Immunogen

Info

Publication number
SG10201704135QA
SG10201704135QA SG10201704135QA SG10201704135QA SG10201704135QA SG 10201704135Q A SG10201704135Q A SG 10201704135QA SG 10201704135Q A SG10201704135Q A SG 10201704135QA SG 10201704135Q A SG10201704135Q A SG 10201704135QA SG 10201704135Q A SG10201704135Q A SG 10201704135QA
Authority
SG
Singapore
Prior art keywords
eliciting
immunogen
immune response
immune
response
Prior art date
Application number
SG10201704135QA
Inventor
Nallani Madhavan
Decaillot Fabien
Zhikang Fu
Xingfang Su
Original Assignee
Agency Science Tech & Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agency Science Tech & Res filed Critical Agency Science Tech & Res
Publication of SG10201704135QA publication Critical patent/SG10201704135QA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/385Haptens or antigens, bound to carriers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Liposomes
    • A61K9/1271Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A61K9/1273Polymersomes; Liposomes with polymerisable or polymerised bilayer-forming substances
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55566Emulsions, e.g. Freund's adjuvant, MF59
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/60Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6093Synthetic polymers, e.g. polyethyleneglycol [PEG], Polymers or copolymers of (D) glutamate and (D) lysine
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/16011Orthomyxoviridae
    • C12N2760/16111Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Virology (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Pulmonology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
SG10201704135QA 2012-11-19 2013-11-11 Method For Eliciting An Immune Response To An Immunogen SG10201704135QA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SG2012084836 2012-11-19

Publications (1)

Publication Number Publication Date
SG10201704135QA true SG10201704135QA (en) 2017-06-29

Family

ID=54321064

Family Applications (2)

Application Number Title Priority Date Filing Date
SG11201503876YA SG11201503876YA (en) 2012-11-19 2013-11-11 Method for eliciting an immune response to an immunogen
SG10201704135QA SG10201704135QA (en) 2012-11-19 2013-11-11 Method For Eliciting An Immune Response To An Immunogen

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SG11201503876YA SG11201503876YA (en) 2012-11-19 2013-11-11 Method for eliciting an immune response to an immunogen

Country Status (8)

Country Link
US (3) US9962438B2 (en)
EP (1) EP2919758B1 (en)
JP (3) JP6453757B2 (en)
CN (2) CN104936579B (en)
MY (1) MY175416A (en)
PH (1) PH12015501101A1 (en)
SG (2) SG11201503876YA (en)
WO (1) WO2014077781A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG11201503876YA (en) * 2012-11-19 2015-06-29 Agency Science Tech & Res Method for eliciting an immune response to an immunogen
US10821078B2 (en) * 2016-06-30 2020-11-03 Northwestern University Nanostructure enhanced targeting (NSET) of inflammatory cells
CN110945076B (en) * 2017-09-12 2023-10-17 苏黎士联邦理工大学 Transmembrane pH-gradient polymer vesicles for quantification of ammonia in body fluids
EP3743101A2 (en) * 2018-01-25 2020-12-02 ACM Biolabs Pte Ltd Polymersomes comprising a soluble encapsulated antigen as well as methods of making and uses thereof
US20220105176A1 (en) 2018-09-12 2022-04-07 Acm Biolabs Pte Ltd Polymersomes comprising a covalently bound antigen as well as methods of making and uses thereof
CN110327298A (en) * 2019-07-30 2019-10-15 天津大学 The preparation method of long-circulating target genophore based on PCL-PEG polymer vesicle
CN114502191A (en) * 2019-08-01 2022-05-13 Acm生物实验室私人有限公司 Method of eliciting an immune response by administering a population of polymersomes with associated antigens and a population of polymersomes with associated adjuvants and composition comprising both populations of polymersomes
EP4138899A2 (en) 2020-04-24 2023-03-01 ACM Biolabs Pte Ltd Vaccine against human-pathogenic coronaviruses
CA3193643A1 (en) 2020-12-11 2022-06-16 Madhavan Nallani Modulating th1/th2 immune response by administering two populations of polymersomes having an associated antigen and an associated adjuvant
AU2022216818A1 (en) 2021-02-02 2023-07-27 Acm Biolabs Pte Ltd Sole use of polymersome associated adjuvant for stimulating an immune response
WO2022218957A1 (en) 2021-04-12 2022-10-20 Acm Biolabs Pte Ltd Polymersomes comprising a soluble encapsulated polynucleotide and an ionizable lipid as well as methods of making and uses thereof
WO2023161378A1 (en) 2022-02-23 2023-08-31 Acm Biolabs Pte Ltd Polymer-lipid hybrid nanoparticles comprising a lipid and a block copolymer as well as methods of making and uses thereof

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6835394B1 (en) * 1999-12-14 2004-12-28 The Trustees Of The University Of Pennsylvania Polymersomes and related encapsulating membranes
US7682603B2 (en) 2003-07-25 2010-03-23 The Trustees Of The University Of Pennsylvania Polymersomes incorporating highly emissive probes
US8821859B2 (en) * 2004-05-19 2014-09-02 Agency For Science, Technology And Research Methods and articles for the delivery of therapeutic agents
US20080312581A1 (en) * 2007-06-06 2008-12-18 Biovaluation & Analysis, Inc. Peptosomes for Use in Acoustically Mediated Intracellular Drug Delivery in vivo
EP2180881A2 (en) 2007-07-20 2010-05-05 Basf Se Vesicles comprising a transmembrane transport trigger system
WO2009076174A1 (en) * 2007-12-05 2009-06-18 The Board Of Trustees Of The University Of Illinois Highly permeable polymer membranes
SG175741A1 (en) * 2009-04-20 2011-12-29 Agency Science Tech & Res Vesicular system and uses thereof
US8470891B2 (en) * 2009-12-23 2013-06-25 International Business Machines Corporation Biodegradable block polymers for drug delivery, and methods related thereto
WO2011109512A1 (en) 2010-03-02 2011-09-09 Vindico Nanobio Technology, Inc. Compositions and methods for treating or preventing immuno-inflammatory disease
GB201008364D0 (en) * 2010-05-20 2010-07-07 Geneve De Composition and method
WO2012018306A1 (en) 2010-08-05 2012-02-09 Agency For Science, Technology And Research A multicompartmentalized vesicular structure and a method for forming the same
GB201111216D0 (en) * 2011-07-01 2011-08-17 Reckitt & Colman Overseas Composition and method
SG11201503876YA (en) * 2012-11-19 2015-06-29 Agency Science Tech & Res Method for eliciting an immune response to an immunogen
WO2016055611A1 (en) * 2014-10-09 2016-04-14 Universität Basel Self-assembled nanostructures and methods of use thereof
EP3743101A2 (en) * 2018-01-25 2020-12-02 ACM Biolabs Pte Ltd Polymersomes comprising a soluble encapsulated antigen as well as methods of making and uses thereof

Also Published As

Publication number Publication date
PH12015501101B1 (en) 2015-07-27
CN104936579B (en) 2020-02-07
US11241494B2 (en) 2022-02-08
US20220133883A1 (en) 2022-05-05
US20180214540A1 (en) 2018-08-02
EP2919758B1 (en) 2020-09-30
CN111450060A (en) 2020-07-28
EP2919758A4 (en) 2016-08-17
EP2919758A1 (en) 2015-09-23
CN104936579A (en) 2015-09-23
WO2014077781A1 (en) 2014-05-22
JP6777705B2 (en) 2020-10-28
JP6453757B2 (en) 2019-01-16
SG11201503876YA (en) 2015-06-29
US9962438B2 (en) 2018-05-08
JP2019011358A (en) 2019-01-24
US20150297711A1 (en) 2015-10-22
PH12015501101A1 (en) 2015-07-27
JP2016500071A (en) 2016-01-07
JP2020183438A (en) 2020-11-12
MY175416A (en) 2020-06-24

Similar Documents

Publication Publication Date Title
SG10201704135QA (en) Method For Eliciting An Immune Response To An Immunogen
ZA201501833B (en) Method for obtaining 1-kestone
GB2501785B (en) Synchronisation method
HK1214640A1 (en) Method for connecting parts relative to one another
ZA201409539B (en) Method for obtaining higher alcohols
HUE050677T2 (en) Structure and method for strain-relieved tsv
SG11201501044RA (en) Extraction method
EP2884522A4 (en) Semiconductor device producing method
HK1204275A1 (en) Method for the preparation of dendritic cell vaccines
EP2937328A4 (en) Alcohol production method
GB201220940D0 (en) Method P
GB201222693D0 (en) Novel method
EP2837619A4 (en) Method for producing beta -alkoxypropionamide
SI2872536T1 (en) Method for extracting biomass
SG11201408326TA (en) Preparation method for perfluoro-2-methyl-3-pentanone and intermediate
PL2809816T3 (en) Expression method
HK1217414A1 (en) Method for manufacturing tea extract
EP2869330A4 (en) Method for producing semiconductor device
HK1206731A1 (en) Method for preparing substituted triazolopyridines
EP2824130A4 (en) Method for producing polydialkylsilane
EP2880048A4 (en) Method
EP2762448A4 (en) Method for preparing silicon oxide
SI2844076T1 (en) Method for obtaining plant proteins
EP2907817A4 (en) Method for preparing cu-btc and nano-cu-btc
ZA201504517B (en) Method for preparing methyl acetate